Idenix +7% as Klarman boosts stake and involvement

Baupost's latest 13D shows a 39.8%, or 53.3M share stake in Indenix Pharmaceuticals (IDIX) vs 35% at last report. Baupost also say's it's engaged management and has been granted observer rights to board meetings.

Shares +7.3% AH

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs